This study demonstrated that AHCC inhibited HSCs activation by inducing cytoglobin through the TLR2-SAPK/JNK pathway and suppressing collagen production via the TLR4-NF-κβ pathway, resulting in the prevention of liver fibrosis progression. The gene discussed is MAPK9; the disease is Hepatic fibrosis.